Cell Analysis Market, By Product (Instruments, and Consumables), By Application (Cell Structure, Identification, Interaction, Viability, Identification and Validation), By End Use and Geography (NA, EU, APAC, and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
REPORT HIGHLIGHT
The cell analysis market is estimated to represent a global market of USD 20.3 billion by 2017 with growth rate of 6.18%.
Market Dynamics
The cell analysis industry thrives on studying the intricacies of an individual cell or a group of cells using scientific processes thus finding novel applications across diverse industries. It finds application in genetics, disease cure, diagnosis and improving overall healthcare facilities. Countries and governments are increasing their spending capacity when it comes to research. The Irish Cancer Society stated that the Government of Ireland invested in over 40 projects that were carried out by the Science Foundation of Ireland. The annual review agenda document mentioned that Science Foundation Ireland awards investment of €43 million through SFI Investigators Programme. Cancer organizations like Cancer Institute of New South Wales (NSW) funded the University of Sydney for live cell analysis.
Studies such as these can prove to be elemental in creating a difference in cancer exploration. In addition, growth in pharmaceuticals and biotechnology acts as a potential catalyst in the growth of this industry due to its direct co-relation. On contrary, market restraint that observed in this industry is the cost of these scientific procedures. Cell analysis requires high level of accuracy and cutting edge technology. Equipment’s required significantly affect the investment cost, thus creating a restriction to the industry. Using such equipment’s requires training and experience thus needs niche human resources as well.
Products Takeaway
The product type can be broadly classified into the instruments and consumables category. Within this market, the consumables segment consists of factors such as assay kits, reagents, microplates etc. Whereas the instrument covers various types of microscopes, PCR systems, flow cyclometers, and cell microarrays. The point of observation here remains that despite being rather inexpensive in comparison to the instruments, the consumables dominate the market share in terms of revenues.
Application Takeaway
In terms of application, the industry is divided into cell research studies, proliferation, viability, and single cell analysis studies. Cancer research remains one of the major areas of revenues. Various steps are being explored in areas such as immunology, neuro and stem cell research. Medical based applications are also prevalent, such as In-Vitro fertilization, circulating tumour, cell detection studies and more. Cancer Research UK stated that they have supported studies worth 413 million pounds, in the year 2017-18.
End Use Takeaway
Some of the direct end users are hospitals, laboratories and other CRO’s. According to the March of Dimes global report on birth defects states that over 6% of Childbirths are ones with genetic deformities. In order to analyse and find a solution proactively, medically based research using cell analysis is being increasingly explored. Owing to the increase in scientific research globally, use of consumables in laboratory and instruments is one of the major end use of this technology.
Regional Takeaway
The prominent areas where this industry is most active are North America, Europe, the Asia Pacific followed by the rest of the world. North America has evidently dominated this industry in the past few years followed by Europe. The major factor is being the rise of biotechnology and pharmaceutical companies in the region. The Asia Pacific has been forecasted to grow exponentially. The major reasons for this can be attributed to the rise in awareness towards health care.
Key Vendor Analysis
Some of the prominent names in the this industry are Becton, Dickinson and Company, GE, Danaher, Olympus Corporation, Agilent Technologies, PerkinElmer, Promega Corporation, Merck KGaA, and Thermo Fisher Scientific. One of the key strategies these companies used in order to grow revenues is begin with novel products such as product up gradation, licenses and certifications. This is a strategy that has contributed to a growth of approx. 56% in certain sectors.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY PRODUCT
Instruments
- Microscopes
- QPCR
- Spectrophotometers
- Cell Counters
- High-Content Screening (HCS) Systems
- Flow Cytometry
- Cell Microarrays
Consumables
- Reagents
- Microplates
- Assay Kits
- Others
MARKET, BY APPLICATION
- Cell Structure Study
- Cell Identification
- Cell Proliferation
- Cell Signaling Pathways/Signal Transduction
- Cell Interaction
- Cell Counting and Quality Control
- Cell Viability
- Target Identification and Validation
- Single-Cell Analysis
MARKET, BY END USE
- Hospitals
- Laboratory
- CROs
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. CELL ANALYSIS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. CELL ANALYSIS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. CELL ANALYSIS INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. CELL ANALYSIS MARKET LANDSCAPE
5.1. Market Share Analysis
6. CELL ANALYSIS MARKET – BY PRODUCT
6.1. Overview
6.2. Instruments
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.3. Microscopes
6.2.3.1. Overview
6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.4. QPCR
6.2.4.1. Overview
6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.5. Spectrophotometers
6.2.5.1. Overview
6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.6. Cell Counters
6.2.6.1. Overview
6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.7. High-Content Screening (HCS) Systems
6.2.7.1. Overview
6.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.8. Flow Cytometry
6.2.8.1. Overview
6.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.9. Cell Microarrays
6.2.9.1. Overview
6.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. Consumables
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3.3. Reagents
6.3.3.1. Overview
6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3.4. Microplates
6.3.4.1. Overview
6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3.5. Assay Kits
6.3.5.1. Overview
6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3.6. Others
6.3.6.1. Overview
6.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. CELL ANALYSIS MARKET – BY APPLICATION
7.1. Overview
7.2. Cell Structure Study
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Cell Identification
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4. Cell Proliferation
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5. Cell Signaling Pathways/Signal Transduction
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.6. Cell Interaction
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.7. Cell Counting and Quality Control
7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.8. Cell Viability
7.8.1. Overview
7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.9. Target Identification and Validation
7.9.1. Overview
7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. CELL ANALYSIS MARKET – BY END USE
8.1. Overview
8.2. Hospitals
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3. Laboratory
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4. CROs
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9. CELL ANALYSIS MARKET– BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.2.3. U.S.
9.2.3.1. Overview
9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.2.4. Canada
9.2.4.1. Overview
9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3. Europe
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.3. France
9.3.3.1. Overview
9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.4. Germany
9.3.4.1. Overview
9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.5. Rest of Europe
9.3.5.1. Overview
9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.3. China
9.4.3.1. Overview
9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.4. India
9.4.4.1. Overview
9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.5. Rest of APAC
9.4.5.1. Overview
9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5. Rest of the World
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5.3. Latin America
9.5.3.1. Overview
9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5.4. Middle East and Africa
9.5.4.1. Overview
9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
10. KEY VENDOR ANALYSIS
10.1. Becton, Dickinson and Company
10.1.1. Company Overview
10.1.2. SWOT Analysis
10.1.3. Key Developments
10.2. GE Healthcare
10.2.1. Company Overview
10.2.2. SWOT Analysis
10.2.3. Key Developments
10.3. Danaher Corporation
10.3.1. Company Overview
10.3.2. SWOT Analysis
10.3.3. Key Developments
10.4. Olympus Corporation
10.4.1. Company Overview
10.4.2. SWOT Analysis
10.4.3. Key Developments
10.5. Agilent Technologies, Inc.
10.5.1. Company Overview
10.5.2. SWOT Analysis
10.5.3. Key Developments
10.6. PerkinElmer
10.6.1. Company Overview
10.6.2. SWOT Analysis
10.6.3. Key Developments
10.7. Promega Corporation
10.7.1. Company Overview
10.7.2. SWOT Analysis
10.7.3. Key Developments
10.8. Merck KGaA
10.8.1. Company Overview
10.8.2. SWOT Analysis
10.8.3. Key Developments
10.9. Thermo Fisher Scientific
10.9.1. Company Overview
10.9.2. SWOT Analysis
10.9.3. Key Developments
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. Abbreviations
12.3. Disclaimer
12.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Cell Analysis Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Cell Analysis Market, by Product, 2014 – 2025 (USD Billion)
Table 11 Cell Analysis Market, by Application, 2014 – 2025 (USD Billion)
Table 12 Cell Analysis Market, by End Use, 2014 – 2025 (USD Billion)
Table 13 Cell Analysis Market, by Geography, 2014 – 2025 (USD Billion)
Table 14 North America Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 15 U.S. Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 16 Canada Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 17 Europe Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 18 France Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 19 Germany Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 20 Asia Pacific Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 21 China Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 22 India Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 23 Latin America Cell Analysis Market, 2014 – 2025 (USD Billion)
Table 24 MEA Cell Analysis Market, 2014 – 2025 (USD Billion)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Cell Analysis Market, by Product, 2014 – 2025 (USD Billion)
Figure 6 Cell Analysis Market, by Application, 2014 – 2025 (USD Billion)
Figure 7 Cell Analysis Market, by End Use, 2014 – 2025 (USD Billion)
Figure 8 Cell Analysis Market, by Geography, 2014 – 2025 (USD Billion)
